Shanghai Kaibao Pharmaceutical CO.,Ltd announced earnings results for the nine months ended September 30, 2020. For the nine months, the company announced sales was CNY 647.783 million compared to CNY 1,063.361 million a year ago. Operating income was CNY 129.613 million compared to CNY 241.650 million a year ago. Net income was CNY 105.737 million compared to CNY 208.297 million a year ago. Basic earnings per share from continuing operations was CNY 0.1011 compared to CNY 0.1991 a year ago.